San Diego Chapter
OBR made its maiden transatlantic expansion to San Diego in early 2012. San Diego is home to one of the largest concentration of biotechnology companies in the world, and also to a myriad of world-class research institutes in the Torrey Pines Mesa, such as the Salk Institute, The Scripps Research Institute, the Sanford-Burnham Medical Research Institute, J. Craig Venter Institute, and University of California, San Diego. Our presence in this biotech cluster puts us in an exclusive environment to forge relationships with both academia and industry, and we look forward to expanding our outreach. Please contact Sybil Wong for enquiries regarding industry partnerships and joining the OBR-San Diego team.
Shuwen is a Ph.D. student working on the transcriptional regulation of E proteins and Id proteins during lymphocyte development at the University of California, San Diego. Besides scientific research, she is also interested in communicating with people to bridge academia and industry in the San Diego area. She expects to achieve this goal through her position as the Outreach and Marketing lead at OBR.
Joshua received a BS in Biology from Texas A&M University in 2005, and a PhD in Cell and Molecular Biology from Baylor College of Medicine in 2011. During his graduate studies, he investigated endocrine regulation of development and lifespan in the nematode Caenorhabditis elegans. He is currently a postdoctoral fellow at the University of California, San Diego, where he studies molecular mechanisms linking obesity, inflammation and insulin resistance in mammalian systems.
Monika is a postdoctoral research associate at the Sanford-Burnham Medical Research Institute. She received her PhD from the University of North Carolina at Chapel Hill. Her research aims to better understand how host innate immune signaling restricts viral infection, with the ultimate goal of identifying potential therapeutic targets. Monika is excited to foster interactions between San Diego’s academic and biotech communities through productive consulting collaborations.
After a stint in the Marv Caruthers Lab at UC Boulder, Curt became a founding member of Applied Biosystems. Curt’s career spans many years of involvement in development of some of the key tools which have led to our understanding of molecular biology, including various generations of DNA synthesis and DNA sequencing, PCR and QPCR. His experience spans a wide array of positions from R&D to product management with global P&L responsibilities to sales and sales management, European marketing and North American customer support management. Curt is a pro-bono advisor with the San Diego Connect Springboard program which helps the San Diego innovation community launch technology businesses and participates in a number of programs that help students get excited about science, technology and business.
Dr. Jiwu Wang earned his Ph.D. degree in Molecular Biology at the University of SouthernCalifornia. He received a NIH postdoctoral fellowship and did his postdoc training in RNA-related fields at UCSD. With a passion for working on cutting edge technologies, he started Allele Biotechnology & Pharmaceuticals in1999 after postdoc and serves as the CEO of the company. He later founded The Scintillon Institute with a focus on bioimaging and photobiology and has been leading its faculty recruitment and fund-raising campaigns. He received more than a dozen NIH grants and contracts, and was an inventor of many patents in RNAi, imaging,diagnostics, skin protection, and stem cells.
Morrison & Foerster is a global law firm with more than 1,000 lawyers in 17 offices in key technology and financial centers in the United States, Europe and Asia. Their clients include some of the largest financial institutions, investment banks, and Fortune 100, technology and life science companies. Morrison & Foerster has been included on The American Lawyer’s A-List for 10 straight years, and Chambers Global named MoFo its 2013 USA Law Firm of the Year. Their lawyers are committed to achieving innovative and business-minded results for our clients, while preserving the differences that make us stronger.
TriLink manufactures custom oligonucleotides, modified nucleoside triphosphates and CleanAmp™ PCR products for the diagnostic and OEM markets. In addition, custom chemistry, long RNA and mRNA synthesis, contract research services and ISO/QSR compliant GMP production facilities are offered. TriLink’s solutions help advance drug discovery and biomedical research. Founded in 1996, TriLink is a privately held firm based in San Diego, California and employs approximately 50 scientists and other professionals. For more information about the firm and products, visit their web site at www.trilinkbiotech.com.
Zhaleh is a PhD candidate in the Biochemistry program at the University of California, San Diego, and previously received her B.S. in Chemistry and Chemical Biology from Cornell University. Currently, her research focuses on RNA catalysis for uses in therapy and as tools in research. Zhaleh is excited to contribute to the growth of OBR and further a connection between academia and industry.
Rachel is a PhD candidate at UCSD and a National Science Foundation Pre-Doctoral Fellow. She is currently studying the signal transduction pathway of NFκB activation. Rachel previously graduated from Boston University with a B.A. in Chemistry.
Kelvin is a PhD candidate at The Scripps Research Institute, USA, and a pre-doctoral fellow of A*STAR, Singapore. He received his B.A.(Hons) in Chemistry at the University of Cambridge, and he currently discovers, develops and optimizes new synthetic methods to functionalize drug molecules.